NCT06666387

Brief Summary

This clinical investigation is used to evaluate the novel PET-MR scanner and it is a clinical investigation under MDR. The focus is on the evaluation of the diagnostic image quality in a clinical setting, considering the speed of the examination and the new functionalities to minimize the patient's lying times. Based on the assessment, the defined protocols and measurement sequences are further improved as necessary to optimize the clinical value of the sequences and user interface components.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 30, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

October 31, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

October 22, 2024

Last Update Submit

April 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the diagnostic image quality (software and hardware) of the novel combined PET-MR system NextGen PET-MR in the clinical setting.

    The outcome of this clinical investigation for conformity assessment according to §62 MDR is the performance and safety to show the indirect clinical benefit. The performance includes diagnostic image quality (including general image quality of the software features, resolution, occurrence of artifacts, etc.) as well as the functionality including system stability of the novel PET-MR system in the clinical setting. The diagnostic image quality, image noise, contrast and resolution for each acquired sequence is rated by two investigators of each specialization (nuclear medicine and radiology) using a 5-point Likert scale. The rating is done for MR images of body regions whole body, total body, brain, head/neck and pelvis fused with PET images of different tracers for all participants. The test in a region of the body is considered successful if the mean value of all scores in that region reaches a value of t ≤ 2.5. In case the mean value for a certain software feature does not reach 2.

    Estimated 5 months

Study Arms (1)

PET-MR examination

OTHER
Diagnostic Test: PET-MR examination

Interventions

PET-MR examinationDIAGNOSTIC_TEST

PET-MR examination

PET-MR examination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult test subjects for whom a PET-MR examination is indicated and will be performed, or
  • Test subjects for whom a PET-CT examination is indicated and will be performed
  • Test subjects of legal age who have given their written informed consent to participate in the clinical investigation
  • Written consent of the test subject to be informed in the event of suspected clinically relevant incidental findings
  • Written consent to the disclosure of a clinically relevant incidental finding to a subsequent physician (release from the duty of confidentiality)
  • The test subject´s written consent that the recorded image data may be made available to Siemens Healthcare A/S in pseudonymized form
  • Test subjects whose weight does not exceed the permissible weight limit of the patient table (200 kg).

You may not qualify if:

  • Metal in and on the body that causes stress to the test subject during an examination in the FoV of the combined PET-MR system
  • All pacemakers and other implants
  • Test subjects who indicate an increased sensitivity to loud noises
  • Test subjects who are incapable of giving consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, Denmark

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2024

First Posted

October 30, 2024

Study Start

October 31, 2024

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

April 23, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations